The Delhi High Court has requested the Centre to present its position regarding a petition filed by a pharmaceutical company that challenges the government’s decision to ban the manufacture, sale, and distribution of certain Fixed Dose Combination (FDC) drugs for human use.
FDC drugs are those that contain a fixed ratio of two or more active pharmaceutical ingredients (APIs).
While issuing notices on three petitions filed by Glenmark Pharmaceuticals Ltd against the ban, the court has directed that the FDC drugs produced by the petitioners, which are already in the distribution channel, should not be withdrawn. It further ordered that no coercive measures be taken against the petitioners.
A Srinagar court has scheduled a hearing for April 8, 2025, in connection with the…
Kannada actress Ranya Rao, arrested last week in connection with a gold smuggling case, has…
The Madhya Pradesh High Court ruled that advocates can represent clients in confiscation cases under…
Cement prices across various states are expected to increase following a Supreme Court ruling that…
The Kerala High Court has laid down new guidelines to protect educators from hasty arrests…
Supreme Court recently opened up the doors for visually impaired candidates in judiciary by striking…